Zobrazeno 1 - 10 of 117 pro vyhledávání: '"PJ Woll"'
3
Dose intensity in small cell lung cancer
Autor: Thatcher N, Siow Ming Lee, Pj, Woll, Middleton M, Anderson H, Burt P, Stout R
Publikováno v: Scopus-Elsevier
Europe PubMed Central
Evidence from preclinical models and from clinical trials describing the importance of dose intensity in securing a better treatment outcome is reviewed. Recent randomized trials have shown statistically significant survival benefits with higher-dose
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6af30ea5d597638a89c9ac15f77fbfe
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031901738&partnerID=MN8TOARS
Zobrazit plný text záznamu
4
Akademický článek
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Autor: Zhao X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Statistics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China., Yang M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Fan J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China.; Health Management Center, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China., Wang M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Wang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China., Qin N; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Zhu M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China., Jiang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Gorlova OY; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas, USA., Gorlov IP; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Lam S; Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Tardón A; Department of Public Health IUOPA, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain., Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Goodman GE; Public Health Sciences Division, Swedish Cancer Institute, Seattle, Washington, USA., Bojesen SE; Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Landi MT; National Cancer Institute, Bethesda, Maryland, USA., Johansson M; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Risch A; Department of Biosciences, Allergy-Cancer-BioNano Research Centre, University of Salzburg, Salzburg, Austria.; Division of Epigenomics and Cancer Risk Factors, DKFZ-German Cancer Research Center, Heidelberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany., Wichmann HE; Institute of Epidemiology, Helmholtz Center Munich, Neuherberg, Germany., Bickeböller H; Department of Genetic Epidemiology, University Medical Center Goettingen, Goettingen, Germany., Christiani DC; Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Rennert G; Technion Faculty of Medicine, Carmel Medical Center, Haifa, Israel., Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA., Brennan P; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Field JK; Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, UK., Shete S; Department of Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Le Marchand L; Epidemiology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii, USA., Liu G; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hung RJ; Prosseman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Andrew AS; Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Zienolddiny S; National Institute of Occupational Health (STAMI), Oslo, Norway., Grankvist K; Department of Medical Biosciences, Umeå University, Umea, Sweden., Johansson M; Department of Radiation Sciences, Umeå University, Umea, Sweden., Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA., Woll PJ; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK., Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Aldrich MC; Department of Medicine (Division of Genetic Medicine), Vanderbilt University Medical Center, Nashville, Tennessee, USA., Patel AV; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA., Davies MPA; Institute of Translational Medicine, University of Liverpool, Liverpool, UK., Ma H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Jin G; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Hu Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Amos CI; Baylor College of Medicine, Institute for Clinical and Translational Research, Houston, Texas, USA., Shen H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China., Dai J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Gusu School, Nanjing Medical University, Nanjing, China.
Publikováno v: Cancer [Cancer] 2024 Mar 15; Vol. 130 (6), pp. 913-926. Date of Electronic Publication: 2023 Dec 06.
Zobrazit plný text záznamu
5
Akademický článek
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
Autor: Woll PJ; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK., Gaunt P; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Gaskell C; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Young R; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK. r.j.young@sheffield.ac.uk., Benson C; Sarcoma Unit, Royal Marsden Hospital, London, UK., Judson IR; Sarcoma Unit, Royal Marsden Hospital, London, UK., Seddon BM; Department of Oncology, University College London Hospital, London, UK., Marples M; St James's University Hospital, Leeds, UK., Ali N; The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK., Strauss SJ; Department of Oncology, University College London Hospital, London, UK., Lee A; The Christie Hospital, Manchester, UK., Hughes A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Kaur B; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Hughes D; University of Sheffield, Sheffield UK and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK., Billingham L; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
Publikováno v: British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (9), pp. 1490-1499. Date of Electronic Publication: 2023 Sep 08.
Zobrazit plný text záznamu
6
Akademický článek
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.
Autor: Luyapan J; Quantitative Biomedical Science Program, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.; Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03756, USA., Bossé Y; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, G1V 0A6, Canada.; Department of Molecular Medicine, Laval University, Quebec City, G1V 0A6, Canada., Li Z; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, G1V 0A6, Canada., Xiao X; Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Rosenberger A; Institut für Genetische Epidemiologie, Georg-August-Universität Göttingen, Gottingen, Niedersachsen, Germany., Hung RJ; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbuaum Research Institute, Sinai Health System, Toronto, ON, M5G 1X5, Canada., Lam S; Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, BC, V5Z 4E6, Canada., Zienolddiny S; Department of Toxicology, National Institute of Occupational Health, Oslo 0033, Norway., Liu G; Princess Margaret Cancer Centre, Princess Margaret Research Institute, Epidemiology Division,Toronto, ON, M5G 1L7, Canada., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, 6525 GA, the Netherlands., Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., McKay J; International Agency for Research on Cancer (IARC/WHO), Genomic Epidemiology Branch Lyon 69008, France., Johansson M; International Agency for Research on Cancer (IARC/WHO), Genomic Epidemiology Branch Lyon 69008, France., Johansson M; Department of Radiation Sciences, Oncology, Umeå University, Umeå, 901 87, Sweden., Tardon A; Health Research Institute of the Principality of Asturias, University of Oviedo and CIBERSP, Oviedo, Asturias, 33071, Spain., Fernandez-Tardon G; Health Research Institute of the Principality of Asturias, University of Oviedo and CIBERSP, Oviedo, Asturias, 33071, Spain., Brennan P; Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig Maximillians University, Munich, Bavaria, 80539, Germany., Field JK; Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, L69 7ZX, UK., Davies MP; Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, L69 7ZX, UK., Woll PJ; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, S10 2AH, UK., Cox A; Department of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2AH, UK., Taylor F; Department of Oncology and Metabolism, University of Sheffield, Sheffield, S10 2AH, UK., Arnold SM; Division of Medical Oncology, Cancer Center, University of Kentucky, Lexington, KY 40508, USA., Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, 99163, USA., Grankvist K; Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, 901 87, Sweden., Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, 20892, USA., Christiani DC; Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA 02115, USA., MacKenzie TA; Quantitative Biomedical Science Program, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.; Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03756, USA., Amos CI; Quantitative Biomedical Science Program, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.; Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03756, USA.; Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.
Publikováno v: Human molecular genetics [Hum Mol Genet] 2023 Sep 05; Vol. 32 (18), pp. 2842-2855.
Zobrazit plný text záznamu
7
Akademický článek
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.
Autor: Rosenberger A; Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany. arosenb@gwdg.de.; Institut Für Genetische Epidemiologie, Universitätsmedizin Göttingen, Humboldtallee 32, 37073, Göttingen, Germany. arosenb@gwdg.de., Muttray N; Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany., Hung RJ; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Canada., Christiani DC; Department of Environmental Health, Harvard T.H. Chan School of Public Health and Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA., Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA., Liu G; Medical Oncology and Medical Biophysics, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Medicine and Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Bojesen SE; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen, Denmark., Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA., Aldrich MC; Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA., Tardon A; Faculty of Medicine, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain., Fernández-Tardón G; Faculty of Medicine, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain., Rennert G; Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel., Field JK; Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Liverpool, UK., Davies MPA; Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Liverpool, UK., Liloglou T; Department of Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool, Liverpool, UK., Kiemeney LA; Departments of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, WA, USA., Wendel B; Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany., Haugen A; National Institute of Occupational Health, Oslo, Norway., Zienolddiny S; National Institute of Occupational Health, Oslo, Norway., Lam S; British Columbia Cancer Agency, Vancouver, BC, Canada., Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Andrew AS; Department of Epidemiology, Geisel School of Medicine, Hanover, NH, USA., Duell EJ; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Goodman GE; Swedish Medical Group, Seattle, WA, USA., Chen C; Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Doherty JA; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Taylor F; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Cox A; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Woll PJ; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Risch A; University of Salzburg and Cancer Cluster Salzburg, Salzburg, Austria., Muley TR; Member of the German Center for Lung Research (DZL), Translational Lung Research Center (TLRC) Heidelberg, Heidelberg, Germany.; Translational Research Unit, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany., Johansson M; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Brennan P; International Agency for Research on Cancer, World Health Organization, Lyon, France., Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, USA., Shete SS; Department of Biostatistics, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amos CI; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Bickeböller H; Department of Genetic Epidemiology, University Medical Center, Georg-August-University Göttingen, Göttingen, Germany.
Publikováno v: European journal of medical research [Eur J Med Res] 2022 Jan 31; Vol. 27 (1), pp. 14. Date of Electronic Publication: 2022 Jan 31.
Zobrazit plný text záznamu
8
Akademický článek
Oncolytic herpesvirus therapy for mesothelioma - A phase I/IIa trial of intrapleural administration of HSV1716.
Autor: Danson SJ; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK. Electronic address: s.danson@sheffield.ac.uk., Conner J; Virttu Biologics/Sorrento Therapeutics, Biocity Scotland, Newhouse, UK., Edwards JG; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Blyth KG; Pleural Disease Unit, Queen Elizabeth University Hospital, Glasgow, UK; Institute of Infection, Immunity and Inflammation, University of Glasgow, UK., Fisher PM; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Muthana M; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Salawu A; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Taylor F; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Hodgkinson E; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Joyce P; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK., Roman J; Virttu Biologics/Sorrento Therapeutics, Biocity Scotland, Newhouse, UK., Simpson K; Virttu Biologics/Sorrento Therapeutics, Biocity Scotland, Newhouse, UK., Graham A; Virttu Biologics/Sorrento Therapeutics, Biocity Scotland, Newhouse, UK., Learmonth K; Virttu Biologics/Sorrento Therapeutics, Biocity Scotland, Newhouse, UK., Woll PJ; Sheffield Experimental Cancer Medicine Centre and Weston Park Cancer Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK.
Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Dec; Vol. 150, pp. 145-151. Date of Electronic Publication: 2020 Oct 20.
Zobrazit plný text záznamu
9
Akademický článek
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.
Autor: Fennell DA; Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of Leicester & University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. df132@leicester.ac.uk., Danson S; Sheffield ECMC, University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom., Woll PJ; Sheffield ECMC, University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom., Forster M; UCL Hospitals & CRUK Lung Cancer Centre of Excellence, London, United Kingdom., Talbot D; Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom., Child J; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Farrelly L; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Sharkey A; Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of Leicester & University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Busacca S; Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of Leicester & University Hospitals of Leicester NHS Trust, Leicester, United Kingdom., Ngai Y; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Hackshaw A; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom., Wheeler GM; Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Sep 15; Vol. 26 (18), pp. 4748-4755. Date of Electronic Publication: 2020 Jul 15.
Zobrazit plný text záznamu
10
Akademický článek
Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.
Autor: Wang Y; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China., Gorlova OY; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas., Gorlov IP; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas., Zhu M; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China., Dai J; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China., Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Lam S; Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Tardon A; Department of Public Health IUOPA, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain., Chen C; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington., Goodman GE; Public Health Sciences Division, Swedish Cancer Institute, Seattle, Washington., Bojesen SE; Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Landi MT; National Cancer Institute, Bethesda, Maryland., Johansson M; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Risch A; University of Salzburg, Department of Biosciences, Allergy-Cancer-BioNano Research Centre, Salzburg, Austria.; Division of Epigenomics and Cancer Risk Factors, DKFZ-German Cancer Research Center, Heidelberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany., Wichmann HE; Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig Maximilians University, Munich, Bavaria, Germany.; Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), Institute of Epidemiology, Neuherberg, Germany.; Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, Germany., Bickeboller H; Department of Genetic Epidemiology, University Medical Center Goettingen, Goettingen, Germany., Christiani DC; Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Rennert G; Technion Faculty of Medicine, Carmel Medical Center, Haifa, Israel., Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, Kentucky., Brennan P; Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France., Field JK; Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, United Kingdom., Shete S; Department of Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, Texas., Le Marchand L; Epidemiology Program, University of Hawai'i Cancer Center, Honolulu, Hawai'i., Melander O; Clinical Sciences, Lund University, Lund, Sweden.; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden., Brunnstrom H; Clinical Sciences, Lund University, Lund, Sweden., Liu G; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hung RJ; Prosseman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada., Andrew AS; Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Kiemeney LA; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands., Zienolddiny S; National Institute of Occupational Health (STAMI), Oslo, Norway., Grankvist K; Department of Medical Biosciences, Umeå University, Umea, Sweden., Johansson M; Department of Radiation Sciences, Umeå University, Umea, Sweden., Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland., Woll PJ; Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, United Kingdom., Lazarus P; Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington., Schabath MB; Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Aldrich MC; Department of Medicine (Division of Genetic Medicine), Vanderbilt University Medical Center, Nashville, Tennessee., Stevens VL; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia., Ma H; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China., Jin G; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China., Hu Z; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China., Amos CI; Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, Houston, Texas. hbshen@njmu.edu.cn chris.amos@bcm.edu., Shen H; Department of Epidemiology, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China. hbshen@njmu.edu.cn chris.amos@bcm.edu.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China.
Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Jul; Vol. 29 (7), pp. 1423-1429. Date of Electronic Publication: 2020 Apr 10.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje